SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001493152-22-014266
Filing Date
2022-05-18
Accepted
2022-05-18 06:12:57
Documents
12

Document Format Files

Seq Description Document Type Size
1 form-424b4.htm 424B4 2490436
2 form424b4_001.jpg GRAPHIC 6805
3 form424b4_012.jpg GRAPHIC 53780
4 form424b4_014.jpg GRAPHIC 54422
5 form424b4_002.jpg GRAPHIC 54422
6 form424b4_003.jpg GRAPHIC 11468
7 form424b4_005.jpg GRAPHIC 18507
8 form424b4_007.jpg GRAPHIC 13811
9 chart_ogd.jpg GRAPHIC 25633
10 form424b4_008.jpg GRAPHIC 12952
11 form424b4_009.jpg GRAPHIC 15165
12 image_004.jpg GRAPHIC 22461
  Complete submission text file 0001493152-22-014266.txt   2891132
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: 424B4 | Act: 33 | File No.: 333-263326 | Film No.: 22936975
SIC: 2836 Biological Products, (No Diagnostic Substances)